Dupilumab treatment induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma

被引：0
|
作者：
Pavord, I. [1 ]
Pandit-Abid, N. [2 ]
Israel, E. [3 ,4 ]
Szefler, S. [5 ]
Brusselle, G. [6 ]
Rabe, K. [7 ,8 ]
Chen, Z. [9 ]
Altincatal, A. [10 ]
Amin, N. [9 ]
Khan, A. [11 ]
Lederer, D. H. [9 ]
Zhang, Y. [9 ]
Rowe, P. J. [2 ]
Deniz, Y. [9 ]
Amr, R. [9 ]
Jacob-Nara, J. A. [2 ]
Busse, W. W. [12 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Sanofi, Bridgewater, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
[6] Ghent Univ Hosp, Ghent, Belgium
[7] LungenClin Grosshansdorf, Grosshansdorf, Germany
[8] Univ Kiel, Kiel, Germany
[9] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[10] Sanofi, Cambridge, MA USA
[11] Sanofi, Chilly Mazarin, France
[12] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000327
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [41] Dupilumab for children with uncontrolled moderate or severe asthma
    Krandick, Guido
    MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (03) : 196 - 197
  • [42] Dupilumab Improves Lung Function in Children With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, B. L.
    Guilbert, W. T.
    Katelaris, H. C.
    Deschildre, A.
    Liu, D.
    Mannent, P. L.
    Amin, N.
    Laws, E.
    Ruddy, M.
    Ortiz, B.
    Jacob-Nara, A. J.
    Deniz, Y.
    Rowe, J. P.
    Atenhan, A.
    Thakur, M.
    Lederer, J. D.
    Hardin, M.
    PNEUMOLOGIE, 2022, 76 : S40 - S40
  • [43] Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status
    Phipatanakul, W.
    Papadopoulos, N. G.
    Hernandez-Trujillo, V.
    Hamelmann, E.
    Zeiger, R. S.
    Ducharme, F. M.
    Jain, N.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGY, 2023, 78 : 5 - 6
  • [44] Dupilumab Improves Lung Function in Children with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, L. B.
    Guilbert, T. W.
    Katelaris, C. G.
    Deschildre, A.
    Liu, D.
    Mannent, L. P.
    Laws, E.
    Ruddy, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    PEDIATRIC PULMONOLOGY, 2022, 57 : S97 - S98
  • [45] DUPILUMAB IMPROVES LUNG FUNCTION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE
    Bacharier, Leonard
    Guilbert, Theresa
    Katelaris, Constance
    Deschildre, Antoine
    Liu, Dongfang
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Lederer, David
    Hardin, Megan
    CHEST, 2021, 160 (04) : 1885A - 1887A
  • [46] Dupilumab Efficacy in Patients with Moderate-to-Severe Type 2 Asthma With and Without Elevated Blood Neutrophils
    Bleecker, E. R.
    Panettieri, R. A.
    Lugogo, N. L.
    Corren, J.
    Daizadeh, N.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Khodzhayev, A.
    Ortiz, B.
    Ferro, T. J.
    Hansen, C. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [47] Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
    Jackson, Daniel J.
    Bacharier, Leonard B.
    Phipatanakul, Wanda
    Sher, Lawrence
    Domingo, Christian
    Papadopoulos, Nikolaos
    Modena, Brian
    Li, Ning
    Xia, Changming
    Kamal, Mohamed A.
    Dillon, Myles
    Wolfe, Kelley
    Gall, Rebecca
    Amin, Nikhil
    Mannent, Leda P.
    Laws, Elizabeth
    Rowe, Paul J.
    Jacob -Nara, Juby A.
    Deniz, Yamo
    Lederer, David J.
    Hardin, Megan
    Xu, Christine
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (01) : 44 - +
  • [48] Dupilumab Efficacy in Children with Uncontrolled, Moderate-to-severe Type 2 Asthma, with and Without Evidence of Allergic Asthma in the VOYAGE Phase 3 Study
    Papadopoulos, Nikolaos G.
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul J.
    PEDIATRICS, 2022, 149 (01)
  • [49] Use of dupilumab on the treatment of moderate-to-severe asthma: a systematic review
    Bassani, Cintia
    Rossi, Larissa
    Siveri, Kaian
    Sferelli, Rafaella Lorenzon
    Saraiva, Leonardo
    Tanno, Luciana Kase
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (09): : 1223 - 1228
  • [50] Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis
    Maspero, Jorge F.
    Katelaris, Constance H.
    Busse, William W.
    Castro, Mario
    Corren, Jonathan
    Chipps, Bradley E.
    Peters, Anju T.
    Pavord, Ian D.
    Ford, Linda B.
    Sher, Lawrence
    Rabe, Klaus F.
    Rice, Megan S.
    Rowe, Paul
    Lu, Yufang
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Pirozzi, Gianluca
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Mannent, Leda P.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 527 - +
12345